Transcriptional regulation of cyclooxygenase-2 gene expression: novel effects of nonsteroidal anti-inflammatory drugs.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cancer Research

• Publication date

  2000-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10706128
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synergy between cyclo‐oxygenase‐2 induction and arachidonic acid supply in vivo: consequences for nonsteroidal antiinflammatory drug efficacy

  1999cited by this paper
• Cyclooxygenase-2 expression in human esophageal carcinoma.

  1999cited by this paper
• Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate.

  1999cited by this paper
• Both Group IB and Group IIA Secreted Phospholipases A2 Are Natural Ligands of the Mouse 180-kDa M-type Receptor*

  1999cited by this paper
• Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.

  1998cited by this paper
• Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.

  1998cited by this paper
• COX-2 inhibitors for colorectal cancer

  1998cited by this paper
• Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas.

  1998cited by this paper
• Resveratrol Inhibits Cyclooxygenase-2 Transcription and Activity in Phorbol Ester-treated Human Mammary Epithelial Cells*

  1998cited by this paper
• Evidence That Porcine Pancreatic Phospholipase A2 via Its High Affinity Receptor Stimulates Extracellular Matrix Invasion by Normal and Cancer Cells*

  1997cited by this paper
• Retinoids suppress phorbol ester-mediated induction of cyclooxygenase-2.

  1997cited by this paper
• Aspirin use and potential mechanisms for colorectal cancer prevention.

  1997cited by this paper
• A Reassessment of the Low Molecular Weight Phospholipase A2 Gene Family in Mammals*

  1997cited by this paper
• Human cancer syndromes: clues to the origin and nature of cancer.

  1997cited by this paper
• A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells.

  1997cited by this paper
• Pancreatic-type Phospholipase A2 Induces Group II Phospholipase A2 Expression and Prostaglandin Biosynthesis in Rat Mesangial Cells

  1997cited by this paper
• Induction of Cyclooxygenase-2 Expression by Peroxisome Proliferators and Non-tetradecanoylphorbol 12,13-Myristate-type Tumor Promoters in Immortalized Mouse Liver Cells*

  1997cited by this paper
• Cyclooxygenase-2 gene expression in human breast cancer.

  1997cited by this paper
• Regulatory functions of phospholipase A2.

  1997cited by this paper
• Expression of cyclooxygenase-2 in human gastric carcinoma.

  1997cited by this paper
• NSAIDs to prevent colorectal cancer: a question of sensitivity.

  1997cited by this paper
• Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).

  1996cited by this paper
• Self-promotion? Intimate connections between APC and prostaglandin H synthase-2.

  1996cited by this paper
• Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells.

  1996cited by this paper
• Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)

  1996cited by this paper
• Lessons from Hereditary Review Colorectal Cancer

  1996cited by this paper
• Aspirin and the risk of colorectal cancer in women.

  1996cited by this paper
• Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.

  1996cited by this paper
• Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2*

  1996cited by this paper
• Prostaglandins, their inhibitors and cancer.

  1996cited by this paper
• Growth of human pancreatic cancer cells, induced by human pancreatic phospholipase A(2), is mediated via its specific receptor but not via its catalytic property.

  1996cited by this paper
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

  1995cited by this paper
• Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase.

  1995cited by this paper
• Aspirin and the risk of colorectal cancer in women.

  1995cited by this paper
• Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin‐1: a potential mechanism for inflammatory angiogenesis

  1995cited by this paper
• Different Intracellular Locations for Prostaglandin Endoperoxide H Synthase-1 and −2 (*)

  1995cited by this paper
• The C/EBP family of transcription factors.

  1995cited by this paper
• Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer.

  1995cited by this paper
• Prostaglandin G/H Synthase-2 Is a Major Contributor of Brain Prostaglandins in the Newborn (*)

  1995cited by this paper
• Yes, but do they still get headaches?

  1995cited by this paper
• Translocation of the 85-kDa Phospholipase A2 from Cytosol to the Nuclear Envelope in Rat Basophilic Leukemia Cells Stimulated with Calcium Ionophore or IgE/Antigen (*)

  1995cited by this paper
• Calcium-mediated Translocation of Cytosolic Phospholipase A2 to the Nuclear Envelope and Endoplasmic Reticulum (*)

  1995cited by this paper
• Human pancreatic phospholipase A2 stimulates the growth of human pancreatic cancer cell line

  1995cited by this paper
• Cloning and expression of a membrane receptor for secretory phospholipases A2.

  1994cited by this paper
• Prostaglandin endoperoxide synthase-1 and -2 couple to different transmembrane stimuli to generate prostaglandin D2 in mouse bone marrow-derived mast cells.

  1994cited by this paper
• Towards a better aspirin

  1994influential reference
• Molecular cloning of pancreatic group I phospholipase A2 receptor.

  1994cited by this paper
• Pancreatic-type phospholipase A2 induces group II phospholipase A2 expression and prostaglandin biosynthesis in rat mesangial cells.

  1994cited by this paper
• Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.

  1993cited by this paper
• Pancreatic-type phospholipase A2 stimulates prostaglandin synthesis in mouse osteoblastic cells (MC3T3-E1) via a specific binding site.

  1993influential reference
• Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.

  1993cited by this paper
• Redistribution of 5-lipoxygenase and cytosolic phospholipase A2 to the nuclear fraction upon macrophage activation.

  1993cited by this paper
• Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs.

  1993cited by this paper
• Effect of pancreatic type phospholipase A2 on isolated porcine cerebral arteries via its specific binding sites

  1992cited by this paper
• Migration of vascular smooth muscle cells by phospholipase A2 via specific binding sites.

  1992cited by this paper
• Proliferative effect of phospholipase A2 in rat chondrocyte via its specific binding sites.

  1992cited by this paper
• Aspirin use and reduced risk of fatal colon cancer.

  1992cited by this paper
• Porcine pancreatic phospholipase A2-induced contractions of guinea pig lung pleural strips.

  1992cited by this paper
• Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response.

  1992cited by this paper
• Characterization of a high affinity binding site for pancreatic-type phospholipase A2 in the rat. Its cellular and tissue distribution.

  1992cited by this paper
• Aspirin use and reduced risk of fatal colon cancer.

  1991cited by this paper
• Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.

  1991cited by this paper
• LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein.

  1990cited by this paper
• IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP.

  1990cited by this paper
• Genetic Alterations During Colorectal-Tumor Development

  1989cited by this paper
• Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein.

  1989cited by this paper
• Genetic alterations during colorectal-tumor development.

  1988cited by this paper
• The Phospholipases

  1987cited by this paper
• The production of prostanoids in human cancers, and their implications for tumor progression.

  1986cited by this paper
• ALTERATIONS IN THE

  1985cited by this paper
• Prostaglandins in squamous cell carcinoma of the head and neck: A preliminary study

  1985cited by this paper
• Regulation of the immune response by prostaglandins

  1983cited by this paper
• Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells.

  1980cited by this paper

• Emerging functions of C/EBPβ in breast cancer

  2023cites this paper
• Impact of transdermal flunixin administration on serum prostaglandin E2 and cortisol concentrations in piglets following castration.

  2022cites this paper
• Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis

  2021cites this paper
• Prostaglandin E2 directly inhibits the conversion of inducible regulatory T cells through EP2 and EP4 receptors via antagonizing TGF‐β signalling

  2021cites this paper
• Relationship between polymorphisms of the lipid metabolism-related gene PLA2G16 and risk of colorectal cancer in the Chinese population

  2018cites this paper
• Exogenous fatty acids and niacin on acute prostaglandin D2 production in human myeloid cells.

  2017cites this paper
• Effect of Selenium Against Lead-Induced Damage on the Gene Expression of Heat Shock Proteins and Inflammatory Cytokines in Peripheral Blood Lymphocytes of Chickens

  2016cites this paper
• The Antagonistic Effect of Selenium on Lead-Induced Inflammatory Factors and Heat Shock Protein mRNA Level in Chicken Cartilage Tissue

  2016cites this paper
• A network pharmacology approach to determine active ingredients and rationality of herb combinations of Modified-Simiaowan for treatment of gout.

  2015influential citation
• Influence of non-steroidal anti-inflammatory drugs (NSAIDs) on osseointegration of dental implants in rabbit calvaria.

  2015cites this paper
• Chronic Treatment With Ticagrelor Limits Myocardial Infarct Size: An Adenosine and Cyclooxygenase-2–Dependent Effect

  2014cites this paper
• Effects of acute and chronic cold stress on expression of cyclooxygenase-2 and prostaglandin E synthase mRNA in quail intestine.

  2013cites this paper
• Porównanie aktywności esterazy aspirynowej i cholinesterazy w grupach osób zdrowych i chorych

  2013cites this paper
• Gene Expression following Exposure to Celecoxib in Humans: Pathways of Inflammation and Carcinogenesis Are Activated in Tumors but Not Normal Tissues

  2011cites this paper
• Diclofenac enhances allergic responses in a mouse peanut allergy model

  2011cites this paper
• Non-Steroidal Anti-Inflammatory Drugs, DNA Repair and Cancer

  2011cites this paper
• Biomarkers of inflammation in cattle determining the effectiveness of anti-inflammatory drugs.

  2010cites this paper
• Associations between COX-2 polymorphisms, blood cholesterol and risk of acute coronary syndrome.

  2010cites this paper
• The expression and distribution of group IIA phospholipase A2 in human colorectal tumours

  2010cites this paper
• Effects of human parvovirus B19 VP1 unique region protein on macrophage responses

  2009cites this paper
• TITLE: Induction of the p75NTR by Aryl Propionic Acids in Prostate Cancer Cells

  2009cites this paper
• Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study.

  2008cites this paper
• The effects of COX-1 and COX-2 inhibitors on prostaglandin synthesis and the formation of heterotopic bone in a rat model

  2008cites this paper
• Phospholipase A2 as targets for anti-cancer drugs.

  2007cites this paper
• CONTRACT NUMBER Induction of the p 75 NTR by Aryl Propionic Acids in Prostate Cancer Cells

  2007cites this paper
• TITLE: Induction of the p75NTR by Aryl Propionic Acids in Prostate Cancer Cells

  2007cites this paper
• The aryl propionic acid R-flurbiprofen selectively induces p75NTR-dependent decreased survival of prostate tumor cells.

  2007cites this paper
• Regulation of cyclooxygenase-2 expression by cyclic AMP.

  2007cites this paper
• Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex

  2007cites this paper
• Anti-Inflammatory Mechanisms of Phenanthroindolizidine Alkaloids

  2006cites this paper
• ROLES OF CYCLOOXYGENASE-2 IN MICROGLIAL ACTIVATION AND DOPAMINERGIC CELL DEATH

  2006cites this paper
• Effect of Sulindac on Gene Expression in Rectal MucosaLimited Project Grant #071

  2006cites this paper
• cAMP elevating agents suppress secretory phospholipase A(2)-induced matrix metalloproteinase-2 activation.

  2006cites this paper
• Regional protein levels of cytosolic phospholipase A2 and cyclooxygenase-2 in Rhesus monkey brain as a function of age.

  2006cites this paper
• Ceramide-1-phosphate: the "missing" link in eicosanoid biosynthesis and inflammation.

  2005cites this paper
• Review : Cardiovascular Complications of Non-Steroidal Anti-Inflammatory Drugs

  2005cites this paper
• Cardiovascular complications of non-steroidal anti-inflammatory drugs.

  2005cites this paper
• Decrease in cytosolic phospholipase A2alpha mRNA levels by reactive oxygen species via MAP kinase pathways in PC12 cells: effects of dopaminergic neurotoxins.

  2005cites this paper
• Group IB Secretory Phospholipase A2 Promotes Matrix Metalloproteinase-2-mediated Cell Migration via the Phosphatidylinositol 3-Kinase and Akt Pathway*

  2004cites this paper
• The influence on human osteoblasts in vitro of non-steroidal anti-inflammatory drugs which act on different cyclooxygenase enzymes.

  2004cites this paper
• Nimesulide and indomethacin induce apoptosis in head and neck cancer cells.

  2004cites this paper
• Prostaglandin E2 and microsomal prostaglandin E synthase‐2 expression are decreased in the cyclooxygenase‐2‐deficient mouse brain despite compensatory induction of cyclooxygenase‐1 and Ca2+‐dependent phospholipase A2

  2004cites this paper
• Renal Cyclooxygenase-2 (Cox-2)

  2004cites this paper
• Renal cyclooxygenase-2 (COX-2). Physiological, pathophysiological, and clinical implications.

  2004cites this paper
• Antiproliferative effect of nitrosulindac (NCX 1102), a new nitric oxide-donating non-steroidal anti-inflammatory drug, on human bladder carcinoma cell lines.

  2004cites this paper
• Potentiation of Tumor Necrosis Factor α-induced Secreted Phospholipase A2 (sPLA2)-IIA Expression in Mesangial Cells by an Autocrine Loop Involving sPLA2 and Peroxisome Proliferator-activated Receptor α Activation*

  2003cites this paper
• The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.

  2003cites this paper
• Arachidonic acid and colorectal carcinogenesis

  2003cites this paper
• Differential regulation of renin and Cox-2 expression in the renal cortex of C57Bl/6 mice

  2003cites this paper
• Synthase Expression Receptor-Involved Inducible Nitric Oxide 2 A Akt as a Mediator of Secretory Phospholipase

  2003cites this paper
• Gene Modulation by the Cyclooxygenase Inhibitor, Sulindac Sulfide, in Human Colorectal Carcinoma Cells

  2003cites this paper
• The expression of brain cyclooxygenase‐2 is down‐regulated in the cytosolic phospholipase A2 knockout mouse

  2003cites this paper
• Akt as a Mediator of Secretory Phospholipase A2 Receptor-Involved Inducible Nitric Oxide Synthase Expression 1

  2003cites this paper
• Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer.

  2003cites this paper
• Inhibition of cytosolic phospholipase A2 mRNA expression: a novel mechanism for acetylsalicylic acid-mediated growth inhibition and apoptosis in colon cancer cells.

  2003cites this paper
• Nonsteroidal Anti-Inflammatory Drugs, Prostaglandins, and Apc -Driven Intestinal Tumorigenesis

  2003cites this paper
• Gleevec (STI-571) inhibits lung cancer cell growth (A549) and potentiates the cisplatin effect in vitro

  2003cites this paper
• Oral single high‐dose aspirin results in a long‐lived inhibition of anodal current‐induced vasodilatation

  2002cites this paper
• Induction of cyclooxygenase-2 by staurosporine through the activation of nuclear factor for IL-6 (NF-IL6) and activator protein 2 (AP2) in an osteoblast-like cell line.

  2002cites this paper
• In altering the release of glucocorticoids, ketorolac exacerbates the effects of systemic immune stimuli on expression of proinflammatory genes in the brain.

  2002cites this paper
• Selective inhibition of Δ-6 desaturase impedes intestinal tumorigenesis

  2002cites this paper
• Selective inhibition of Delta-6 desaturase impedes intestinal tumorigenesis.

  2002cites this paper
• Chemoprevention of colorectal carcinogenesis

  2002cites this paper
• Relationship betweenAPC genotype, polyp distribution, and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis

  2001cites this paper
• Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms.

  2001cites this paper
• COX-2 Specific Inhibitor, NS-398, Increases Macrophage Migration Inhibitory Factor Expression and Induces Neuroendocrine Differentiation in C4-2b Prostate Cancer Cells

  2001cites this paper
• Protein Kinase C-α Coordinately Regulates Cytosolic Phospholipase A2 Activity and the Expression of Cyclooxygenase-2 through Different Mechanisms in Mouse Keratinocytes

  2001cites this paper
• Nuclear Factor κB Is a Molecular Target for Sulforaphane-mediated Anti-inflammatory Mechanisms*

  2001cites this paper
• Growth inhibition and apoptosis induction of Sulindac on Human gastric cancer cells.

  2001cites this paper
• Pancreatic phospholipase A2 via its receptor regulates the expression of key enzymes of phospholipid and sphingolipid metabolism

  2001cites this paper
• Molecular Characterization of Murine Pancreatic Phospholipase A2

  2001cites this paper
• Transcriptional regulation of gene expression in lung carcinoma cells

  2001cites this paper
• Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation.

  2000cites this paper
• COX-2 inhibition prevents insulin-dependent diabetes in low-dose streptozotocin-treated mice.

  2000cites this paper
• Inhibition of epstein-barr virus early antigen activation promoted by 12-O-tetradecanoylphorbol-13-acetate by the non-steroidal anti-inflammatory drugs.

  2000cites this paper
• New insights into physiological and pathophysiological functions of cyclo-oxygenase-2

  2000cites this paper
• Prostaglandin H synthases and their importance in chemical toxicity.

  2000cites this paper
• Scholarship@Western Scholarship@Western

  year unknowncites this paper